Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 15, 2006 (Vol. 26, No. 2)

New Biomolecules for Cancer Treatment

Real Hope for Safer Drugs on the Horizon

  • At the recent 9th European Biotech Crossroads meeting in Lille, France, Nigel Courtenay-Luck, Ph.D., CSO of Antisoma (www.anti soma.com), presented encouraging safety data from a Phase I study of a new type of biomolecule known as an aptamer. According to Dr. Courtenay-Luck, an aptamer has similar properties to ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.